By Aveluro Research Team · Editorial policy
VDP (VDP) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 40,950 VND, little changed on the session, giving a market capitalization of 1.2 trillion VND.
On valuation, VDP trades at a price-to-earnings ratio of 17.6 and a price-to-book of 1.4. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 8.1% points to modest profitability relative to the company's equity base, below the sector average of 10.4%. Trailing earnings per share stand at 2,792 VND.
Aveluro tracks 1 news item mentioning VDP. The most recent catalyst was a capital raise event — "Vidipha (VDP) Rights Offering: 10M Shares at 10,000 VND to Fund Cephalosporin Line". Aveluro's composite model rates VDP 6.1/10 (Hold), blending news sentiment, price momentum, and fundamentals.
Average daily volume over the past 10 sessions is roughly 3,400 shares; liquidity is relatively thin, so single headlines can move the price sharply. Comparable names in the Health Care sector include AGP, AMV and APC.
What matters now
Vidipha (VDP) Rights Offering: 10M Shares at 10,000 VND to Fund Cephalosporin Line
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.